Patents by Inventor Ute Weiershausen

Ute Weiershausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(2'-aminophenyl)-benzamide derivatives process for the preparation thereof and pharmaceutical compositions containing them
    Patent number: 5137918
    Abstract: The present invention provides substituted N-(2'-aminophenyl)-benzamide derivatives useful for combating neoplastic diseases. The present invention also provides a process for the preparation of these benzamide derivatives, as well as pharmaceutical compositions containing them and methods for using them.
    Type: Grant
    Filed: October 9, 1990
    Date of Patent: August 11, 1992
    Assignee: Goedecke Aktiengesellschaft
    Inventors: Ute Weiershausen, Gerhard Satzinger, Karl-Otto Vollmer, Wolfgang Herrmann
  • N-phenylbenzamide derivatives
    Patent number: 4933368
    Abstract: N-phenylbenzamide derivatives of the general formula I ##STR1## wherein the radicals R.sup.1, R.sup.2, and R.sup.3, which can be the same or different, are a hydrogen atom or a methyl radical, as well as the pharmacologically acceptable salts thereof for controlling refractory tumors in mammals are described.
    Type: Grant
    Filed: May 31, 1989
    Date of Patent: June 12, 1990
    Assignee: Godecke Aktiengesellschaft
    Inventors: Gerhard Satzinger, Manfred Herrmann, Edgar Fritschi, Ute Weiershausen
  • Use of benzothiazepine derivatives as lymphocyte protectors
    Patent number: 4861770
    Abstract: The use of benzothiazepine derivatives for the protection of lymphocytes in humans and higher mammals, especially in the treatment of acquired immune deficiency syndrome.
    Type: Grant
    Filed: February 1, 1988
    Date of Patent: August 29, 1989
    Assignee: Goedecke Aktiengesellschaft
    Inventors: Ute Weiershausen, Volker Ganser, Gerhard Satzinger
  • N-phenylbenzamide derivatives
    Patent number: 4857662
    Abstract: N-phenylbenzamide derivatives of the general formula I ##STR1## wherein the radicals R.sup.1, R.sup.2, and R.sup.3, which can be the same or different, are a hydrogen atom or a methyl radical, as well as the pharmacologically acceptable salts thereof for controlling malignant, proliferative and auto-immune diseases and for immunosuppressive therapy upon grafting are described.
    Type: Grant
    Filed: February 9, 1984
    Date of Patent: August 15, 1989
    Assignee: Godecke Aktiengesellschaft
    Inventors: Gerhard Satzinger, Manfred Hermann, Edgar Fritschi, Ute Weiershausen
  • N-phenylbenzamide derivatives
    Patent number: 4816485
    Abstract: N-phenylbenzamide derivatives of the general formula I ##STR1## wherein the radicals R.sup.1, R.sup.2, and R.sup.3, which can be the same or different, are a hydrogen atom or a methyl radical, as well as the pharmacologically acceptable salts thereof for controlling malignant, proliferative and auto-immune diseases and for immunosuppressive therapy upon grafting are described.
    Type: Grant
    Filed: March 30, 1987
    Date of Patent: March 28, 1989
    Assignee: Warner-Lambert Company
    Inventors: Gerhard Satzinger, Manfred Herrmann, Edgar Fritschi, Ute Weiershausen
  • Pharmaceutical composition with antithrombotic activity
    Patent number: 4724266
    Abstract: The present invention provides combination of materials for strengthening the antithrombotic action of acetylsalicylic acid. It covers a composition which contains diltiazem or a pharmaceutically acceptable acid-addition salt thereof in combination with acetylsalicylic acid. It also forms the new compound diltiazem acetysalicylate. It also covers compositions containing the above and methods for using the compositions or compound.
    Type: Grant
    Filed: July 21, 1987
    Date of Patent: February 9, 1988
    Assignee: Godecke Aktiengesellschaft
    Inventors: Gerhard Satzinger, Gunter Wolf, Hartmut Osswald, Ute Weiershausen